Previsioni di mercato dei test sviluppati in laboratorio per l\'Asia Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipologia (biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia e altri tipi di test) e applicazione (istituti accademici, organizzazioni di ricerca clinica, Laboratori ospedalieri, centri diagnostici specialistici e altri)
Introduzione al mercato
Un test sviluppato in laboratorio (LDT) è un tipo di test diagnostico in vitro progettato e utilizzato all\'interno un unico laboratorio. Questi test possono essere utilizzati per stimare o distinguere un vasto assortimento di materiali di analiti come proteine, composti chimici come glucosio o colesterolo o DNA, da un campione ricevuto dall\'anatomia umana. Si prevede che l\'espansione dei metodi di diagnostica in vitro automatizzata (IVD) per laboratori e dispensari per eseguire analisi precise e prive di errori alimenterà l\'incremento.
Panoramica e dinamiche del mercato
Si prevede che il mercato dei test sviluppati in laboratorio nell\'Asia del Pacifico raggiungerà i 4.028,17 dollari USA milioni di dollari entro il 2028 da 2.372,68 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 7,9% dal 2021 al 2028. I fattori chiave che attribuiscono la crescita del mercato sono la crescente incidenza di cancro e malattie genetiche e la crescente automazione dei processi di laboratorio in tutto il mondo. il globo. Tuttavia, il mutevole panorama normativo sta ostacolando la crescita del mercato dei test di sviluppo di laboratorio nell’Asia del Pacifico.
L\'automazione sta emergendo come approccio per ridurre al minimo il coinvolgimento umano nei processi di laboratorio. L\'automazione delle procedure di laboratorio di routine con l\'ausilio di workstation dedicate e software di sistema aiuta ad aumentare l\'efficienza e a ridurre gli errori umani. I laboratori stanno adottando sempre più sistemi di gestione delle informazioni di laboratorio (LIMS) e altri strumenti di automazione per mantenere una rigorosa conformità normativa, aumentare l’efficienza e la produttività e migliorare la sicurezza e l’integrità dei dati. Secondo lo studio pubblicato sul Journal of Lab Automation, le frequenze di errore nelle operazioni completamente automatizzate, semiautomatiche e manuali sono rispettivamente dell\'1-5%, dell\'1-10% e del 10-30%. Inoltre, gli elevati volumi di dati generati dai sistemi di laboratorio stanno innescando la domanda di metodi efficaci di elaborazione, analisi e condivisione dei dati, evidenziando così la necessità di soluzioni efficienti ed economicamente vantaggiose come il LIMS. L’automazione degli LDT può aumentare significativamente la produttività e semplificare le procedure di conformità. I laboratori clinici sono sottoposti a un’enorme pressione per gestire volumi crescenti di test e condurre test diagnostici più complessi, sottolineando ulteriormente la necessità di sistemi di automazione flessibili. Molte aziende MedTech offrono soluzioni di automazione per contribuire a semplificare i processi di laboratorio clinico. Ad esempio, Roche Cobas Omni-Utility Channel è vantaggioso sia per i test IVD che per gli LDT ad alto volume. È progettato per soddisfare la crescente esigenza di flussi di lavoro efficienti nei laboratori, in quanto può assistere in diverse fasi che vanno dall\'elaborazione dei campioni alla rapida interpretazione dei dati. Può eseguire fino a 96 risultati in 3 ore e fino a 864 risultati in 8 ore, migliorando così l\'efficienza dei laboratori. Inoltre, la crescente incidenza del cancro e la crescente consapevolezza sull\'importanza della diagnosi precoce stanno stimolando l\'adozione degli LDT.
L\'epidemia di COVID-19 ha spinto la diagnostica in prima linea nell\'assistenza sanitaria. e una maggiore consapevolezza sui test di qualità in tutto il mondo. Molti paesi dell’Asia del Pacifico hanno adottato misure straordinarie per contenere l’infezione aumentando la capacità di test. Ad esempio, il nuovo \"Regolamento per l\'amministrazione e la supervisione dei dispositivi medici\" L\'ordine 739 LDT, che consente lo sviluppo di test sviluppati in laboratorio (LDT), è stato rilasciato in Cina nel marzo 2021. Questo nuovo regolamento allenta le restrizioni sugli LDT in Cina, consentendo alle istituzioni mediche cinesi di sviluppare i propri reagenti IVD a determinate condizioni. Inoltre, l’allentamento delle normative governative relative agli LDT sta ulteriormente guidando la crescita del mercato nella regione. Inoltre, l’aumento dei lanci di prodotti da parte degli operatori del mercato stanno ulteriormente guidando la crescita del mercato. Pertanto, tali sviluppi daranno impulso al mercato dei test sviluppati in laboratorio nell\'Asia del Pacifico.
Segmenti chiave del mercato
Il mercato dei test sviluppati in laboratorio nell\'Asia del Pacifico, per tipologia, è segmentato in biochimica clinica, terapia intensiva, ematologia, microbiologia, diagnostica molecolare, immunologia e altri test. tipi. Il segmento ematologico è stato suddiviso in coagulazione ed emostasi, test dell\'emoglobina, test dell\'emocromo e altri. Si prevede che il segmento della diagnostica molecolare deterrà la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento dell\'ematologia registrerà il CAGR più elevato durante il periodo di previsione.
Il laboratorio dell\'Asia Pacifico Il mercato dei test sviluppati, per applicazione, è segmentato in istituti accademici, organizzazioni di ricerca clinica, laboratori ospedalieri, centri diagnostici specializzati e altri. Si prevede che il segmento dei laboratori ospedalieri deterrà la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento dei centri diagnostici specialistici registrerà il CAGR più elevato durante il periodo di previsione.
Principali fonti e aziende elencate
Alcune di le fonti primarie e secondarie a cui si fa riferimento durante la preparazione del rapporto sul mercato dei test sviluppati in laboratorio nell\'Asia del Pacifico sono la China Food and Drug Administration (CFDA), il Ministero della salute, del lavoro e del welfare (MHLW) e il National Cancer Institute (NCI).
Motivi per acquistare il rapporto
- Determinare potenziali aree di investimento sulla base di un\'analisi dettagliata delle tendenze del mercato di prova sviluppato in laboratorio nell\'Asia Pacifico < nei prossimi anni.
- Acquisire una comprensione approfondita dei fattori sottostanti che guidano la domanda di diverse terapeutiche per la dipendenza segmenti nei paesi con la maggiore spesa e identificare le opportunità offerte da ciascuno di essi.
- Rafforzare la tua conoscenza del mercato in termini di fattori trainanti della domanda, tendenze del settore e tecnologie più recenti sviluppi, tra gli altri.
- Identificare i principali canali che guidano il mercato del diltiazem nell\'Asia Pacifico, fornire un quadro chiaro delle opportunità future che aiuterà ad analizzare, con conseguente espansione delle entrate.
- Canalizzare le risorse concentrandosi sui programmi in corso intrapresi dai diversi paesi all\'interno del Mercato dei test sviluppato dai laboratori dell\'Asia Pacifico.
SEGMENTAZIONE DEL MERCATO DI PROVA SVILUPPATO DA LABORATORIO ASIA PACIFICO
Per tipo
- Biochimica clinica
- Area critica
- Ematologia
- Coagulazione ed emostasi,
- Test dell\'emoglobina
- Esame del sangue
- Altro
- Immunologia
- Microbiologia
- Diagnostica molecolare
- Altri tipi di test
Per applicazione
- Istituti accademici
- Organizzazioni di ricerca clinica
- Laboratori ospedalieri
- Centri diagnostici specializzati
- Altri
Di Paese
- India
- Giappone
- < span>Cina
- Corea del Sud
- Australia
- Resto del Asia Pacifico
Profili aziendali
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Laboratory Developed Test Market – By Type
1.3.2 Asia Pacific Laboratory Developed Test Market – By Application
1.3.3 Asia Pacific Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Asia Pacific Analysis
6.1 Asia Pacific Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Asia Pacific Analysis
9.1 Asia Pacific: Laboratory Developed Test Market
9.1.1 Overview
9.1.3 Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.3.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.2 China: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.1.2.1 China: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.1.3 China: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.2 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.1 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.2 Japan: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.2.2.1 Japan: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.2.3 Japan: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.3 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.1 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.2 India: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.3.2.1 India: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.3.3 India: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.4 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.1 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.2 Australia: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.4.2.1 Australia: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.4.3 Australia: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.1 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.2 South Korea: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.5.2.1 South Korea: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.5.3 South Korea: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5.4 South Korea: Laboratory Developed Test Market, by End User, 2019–2028 (USD Million)
9.1.3.6 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.1 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.2 Rest of Asia Pacific: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.6.2.1 Rest of Asia Pacific: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.6.3 Rest of Asia Pacific: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Incidence Rate Of Cancer in 2018 in China
Table 2. China: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Laboratory Developed Test Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. India: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 9. India Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Laboratory Developed Test Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Asia Pacific: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 22. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 23. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Asia Pacific Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Asia Pacific Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Asia Pacific Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 23. China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.